凝血酶原基因G20210A突变与复发性静脉血栓栓塞的相关性:一项荟萃分析的证据
本荟萃分析系统检索PubMed和Scopus的前瞻性研究,纳入16项研究共16,174名参与者,评估凝血酶原G20210A突变与复发性静脉血栓栓塞风险的关系。结果显示,G20210A突变携带者复发风险增加(RR=1.60,95%CI=1.20-2.14),杂合子(GA vs GG)风险亦增加(RR=1.79,95%CI=1.24-2.57),但GA/AA突变未见风险增加;该关联在长期随访(≥5年)中显著,短期随访(<5年)中不显著。
要点
- 凝血酶原G20210A突变携带者复发性静脉血栓栓塞风险增加(RR=1.60,95%CI=1.20-2.14)。
- 杂合子(GA vs GG)复发风险增加(RR=1.79,95%CI=1.24-2.57),但GA/AA突变未见风险增加。
- 该关联在随访≥5年时显著,在随访<5年时不显著。
核心结论
- 凝血酶原G20210A突变与复发性静脉血栓栓塞风险增加相关,该关联在长期随访(≥5年)中显著,在短期随访(<5年)中不显著。
研究设计与样本
- 系统检索PubMed和Scopus的前瞻性研究,纳入16项研究共16,174名参与者,采用相对风险(RR)及95%置信区间(CI)评估关联。
主要发现
- G20210A突变携带者较非携带者复发性静脉血栓栓塞风险增加(RR=1.60,95%CI=1.20-2.14)。
- 杂合子(GA vs GG)复发风险增加(RR=1.79,95%CI=1.24-2.57),但GA/AA突变未见风险增加。
- 该关联在长期随访(≥5年)中显著,在短期随访(<5年)中不显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prothrombin (PT) G20210A mutation is one of the most prevalent genetic variations associated with an increased susceptibility to the first episode of venous thromboembolism (VTE). However, it remains uncertain whether this inherited thrombophilic abnormality also poses a risk for recurrent VTE. This meta-analysis aimed to assess the relation of PT G20210A mutation to the risk of recurrent VTE. METHODS: PubMed and Scopus were systematically searched for pertinent prospective studies. Relative risks (RR) and 95% confidence intervals (CI) were used to test the association. Sixteen studies, with 16,174 participants, were included. RESULTS: Carriers of the G20210 A mutation were at increased risk of recurrent VTE (RR = 1.60, 95% CI = 1.20-2.14) compared to noncarriers; the increased risk was observed in heterozygotes (GA versus GG) (RR = 1.79, 95% CI = 1.24-2.57), but not in GA/AA mutation. CONCLUSIONS: This association was found to be significant in the long term (≥5 years of follow-up), but not in the short term (<5 years of follow-up).
引用
- Wang Z, Wu H. The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis. Ann Vasc Surg. 2024. PMID: 39096951. doi:10.1016/j.avsg.2024.06.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。